Moneycontrol PRO

Buy Ipca Laboratories; target of Rs 1085: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1085 in its research report dated May 26, 2022.

May 30, 2022 / 06:32 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher's research report on Ipca Laboratories


IPCA Lab’s (IPCA) Q4 performance was impacted by weak exports, however API, UK and branded generics issues should normalize from H2FY23, in our view. Domestic business (45% of total sales) remained strong and it will continue to outperform IPM. Strong API capabilities and diversified model have benefited IPCA in the current environment. Our FY23E and FY24E EBIDTA stands reduced by 3% yet PAT cut is higher by 7-10%, as management indicated 25% tax rate vs 22-23% earlier.



Outlook


We recommend ‘Buy’ rating with revised TP of Rs 1,085 based on 23x FY24E earnings.

Close

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: May 30, 2022 06:32 pm
Sections
ISO 27001 - BSI Assurance Mark